Feb 14, 2021

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience

JACC. Cardiovascular interventions

Neil P Fam, Ralph Stephan von Bardeleben, Mark Hensey, Susheel K Kodali, Robert L Smith, Jörg Hausleiter, Geraldine Ong, Robert Boone, Tobias Ruf, Isaac George, Molly Szerlip, Michael Näbauer, Faeez M Ali, Robert Moss, Vinayak Bapat, Katharina Schnitzler, Felix Kreidel, Jian Ye, Djeven P Deva, Michael J Mack, Paul A Grayburn, Mark D Peterson, Martin B Leon, Rebecca T Hahn, John G Webb

CONCLUSIONS: This first-in-human experience evaluating EVOQUE TTVR demonstrated high technical success, acceptable safety, and significant clinical improvement. Larger prospective studies are needed to confirm durability and safety and the impact on long-term clinical outcomes.

Read Article

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience

Share This